Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response
Clinical trial NCT06116461 · UNKNOWN
Trial details
- NCT number
- NCT06116461
- Sponsor
- Erasmus Medical Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-05
- Primary completion
- 2024-10-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.